»As Two Covid Vaccines Get Clearance in India, AIIMS Chief Says Mass Rollout to Start in 2 Weeks
1-MIN READ
As Two Covid Vaccines Get Clearance in India, AIIMS Chief Says Mass Rollout to Start in 2 Weeks
File photo of AIIMS Director and member of the National Task Force on COVID19, Dr Randeep Guleria. (Photo: ANI)
The expert panel of the drug regulator has recommended emergency use authorisations to two vaccines - Oxford AstraZeneca s Covishield and Bharat Biotech s Covaxin.
FOLLOW US ON:
All India Institute of Medical Sciences (AIIMS) Director Dr. Randeep Guleria on Saturday said India was ready for a mass rollout of the Covid-19 vaccine within the coming 10 to 14 days, as the expert panel of the drug regulator recommended emergency use authorisations to two vaccines - Oxford AstraZeneca s Covishield and Bharat Biotech s Covaxin.
NEW DELHI: Experts at India's drugs regulator have recommended for emergency use two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other backed by a state-run institute, the government said on Saturday. A government minister said earlier the AstraZeneca/Oxford vaccine had been given the green light on Friday, paving the way for a huge
A sample number of beneficiaries will undergo a mock immunisation process. Staff of vaccination centres, a select group of healthcare workers will participate in the mock immunisation drive
Experts at India's drugs regulator have recommended two coronavirus vaccines for emergency use, one developed by AstraZeneca and Oxford University and the other backed by a state-run institute.